GLP-1 receptor agonists are a class of drugs that mimic the action of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). These drugs work by enhancing insulin secretion, inhibiting glucagon release, and delaying gastric emptying, thus improving glucose control in patients with type 2 diabetes.
